Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Phase 3 Randomized, Double Blind, Placebo-Controlled Parallel Group Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects with Moderately to Severely Active UC (UNIFI)
Flomenhoft, Deborah
(PI)
Internal Medicine
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
3/31/16
→
6/30/18
Funding
Janssen Research and Development LLC:
$14,696.00
View all
View less